SlideShare a Scribd company logo
1 of 33
TOPIC- GENE EXPRESSION VECTOR
PRESENTED BY:
TAHURA MARIYAM
MSc. MICROBIOLOGY
PRENENTED TO: Dr. Gurudayal Ram (Assistant prof. Sr. Grade)
DEPARTMENT OF INDUSTRIAL MICROBIOLOGY
JACOB INSTITUTE OF BIOTECHNOLOGY AND BIO-ENGINEERING
SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE,TECHNOLOGY, AND SCIENCES,
PRAYAGRAJ
Content
1. INTRODUCTION
2. ELEMENTS OF EXPRESSION VECTOR
3. ELEMENTS OF EXPRESSION
4. PROTEIN TAGS
5. OTHERS
6. EXPRESSION/PRODUCTION VECTOR
 BACTERIA
 YEAST
 CELL-FREE SYSTEM
7. APPLICATION
 PRODUCTION OF PEPTIDE AND PROTEIN PHARMACEUTICALS
Introduction
 An expression vector, otherwise known as an expression construct, is usually a plasmid or
virus designed for gene expression in cells. The vector is used to introduce a specific gene
into a target cell, and can commandeer the cell's mechanism for protein synthesis to
produce the protein encoded by the gene. Expression vectors are the basic tools in
biotechnology for the production of proteins.
 The vector is engineered to contain regulatory sequences that act as enhancer and
promoter regions and lead to efficient transcription of the gene carried on the expression
vector. The goal of a well-designed expression vector is the efficient production of protein,
and this may be achieved by the production of significant amount of stable messenger
RNA, which can then be translated into protein. The expression of a protein may be tightly
controlled, and the protein is only produced in significant quantity when necessary
through the use of an inducer, in some systems however the protein may be expressed
constitutively. Escherichia coli is commonly used as the host for protein production, but
other cell types may also be used. An example of the use of expression vector is the
production of insulin, which is used for medical treatments of diabetes.
Expression Vector
 The cloning vector containing suitable expression signals to have
maximum gene for expression is called expression vector.
 The following expression signals are introduced into gene cloned vectors
are get maximum expression
 Insertion of strong promoter.
 Insertion of strong termination codon.
 Adjustment of distance between promoter and cloned gene.
 Insertion of transcription termination sequence.
Choice of expression vector
 Strong promoter
 Intact ORF
 Ribosomal binding site
 Termination sequence
Expression in Prokaryotes
 Promoter-commonly used inducible promoter are promoters derived
from lac operon and the T7 promoter. Other strong promoters used
include Trp
 promoter and Tac promoter, which a hybrid of both the Trp and Lac
operon promoters
 Ribosome binding site(RBS) following the promoter, and promoter
efficient translation of the protein of interest.
 Translation initiation site-shine dalgarno sequence enclosed in the RBS,8
base-pair upstream of the AUG start codon.
Post-Translational Modification
 Eukaryotic protein synthesis occurs in cytoplasm or on the endoplasmic
reticulum.
 These protein are further are further post translation processed that is
required for protein activity and stability.
 Disulfide isomerase also make sure that the proteins produced have the
correct configuration
 The proper glycosylation that are necessary for protien conformation,
localization by interacting with specific receptor and increase stability.
Eukaryotic Expression System
 Eukaryote expression vectors require sequence that encode for.
 Polyadenylation tail: creates a polyadenylation tail at the end of the
transcribed pre-mRNA that protects mRNA from exonucleases and
ensures transcriptional termination: stabilizers mRNA production.
 Minimal UTR length: UTRs contains a specific characteristics that may
impede transcriptional or translation, and thus the shortest UTRs or none
at are encoded for in optimal expression vectors.
 Kozak sequence: vectors should encode for a Kozak sequence in the m
RNA, which assembles the ribosome for translation of the m RNA.
Eukaryotic Expression System contd….
 Eukaryote expression vector require sequence that encode for.
 Polyadenylation tail: creates a polyadenylation tail at the end of the
transcribed pre-m RNA that protects the m RNA fromexonucleases and
ensure transcriptional and translational termination: stabilizers m RNA
production.
 Minimal UTR length: UTRs contains specific characteristics that may
impede transcription or translation, and thus the shortest UTRs or none at
all are encoded for in optimal expression vectors.
 Kozak sequence: vectors should encode encode for kozak sequence in the
m RNA, which assembles the ribosome for translation of the m RNA.
Element of of expression vector
 An expression vector has features that any vector may have, such as an
origin of replication, a selectable marker, and a suitable site for the
insertion of a gene like the multiple cloning site. The cloned gene may be
transferred from a specialized cloning vector to an expression vector,
although it is possible to clone directly into an expression vector. The
cloning process is normally performed in Escherichia coli. Vectors used for
protein production in organisms other than E.coli may have, in addition to
a suitable origin of replication for its propagation in E. coli, elements that
allow them to be maintained in another organism, and these vectors are
called shuttle vectors.
 The major feature of a eukaryotic expression vector are a promoter, a
multiple cloning site, DNA segment for termination and polyadenylation,
selectable marker, original of replication in E.coli and eukaryotic cell and
Ampr for marker in E.coli
Eukaryotic Expression System
 Saccharomyces cerevisiae
 Pichia pastoris
 Baculovirus-insect cell lines
 Mammalian systems
Elements of Expression Vector contd….
 An expression vector must have elements necessary for gene expression. These may
include a promoter, the correct translation initiation sequence such as a ribosomal
binding site and start codon, a termination codon, and a transcription termination
sequence. There are differences in the machinery for protein synthesis between
prokaryotes and eukaryotes, therefore the expression vectors must have the elements
for expression that are appropriate for the chosen host. For example, prokaryotes
expression vectors would have a Shine- Dalgarno sequence at its translation initiation
site for the binding of ribosomes, while eukaryotes expression vectors would contain the
Kozak consensus sequence.
 The promoter initiates the transcription and is therefore the point of control for the
expression of the cloned gene. The promoters used in expression vector are normally
inducible, meaning that protein synthesis is only initiated when required by the
introduction of an inducer such as IPTG. Gene expression however may also be
constitutive (i.e. protein is constantly expressed) in some expression vectors. Low level of
constitutive protein synthesis may occur even in expression vectors with tightly
controlled promoters.
Protein Tags
After the expression of the gene product, it is usually necessary to purify the expressed protein;
however, separating the protein of interest from the great majority of proteins of the host cell
can be a protracted process. To make this purification process easier, a purification tag may
be added to the cloned gene. This tag could be histidine (His) tag, other marker peptides, or a
fusion partners such as glutathione S-transferase or maltose-binding protein. Some of these
fusion partners may also help to increase the solubility of some expressed proteins. Other
fusion proteins such as green fluorescent protein may act as a reporter gene for the
identification of successful cloned genes, or they may be used to study protein expression in
cellular imaging.
OTHERS:
The expression vector is transformed or transfected into the host cell for protein synthesis.
Some expression vectors may have elements for transformation or the insertion of DNA into
the host chromosome, for example the vir genes for plant transformation, and integrase sites
for chromosomal integration. Some vectors may include targeting sequence that may target
the expressed protein to a specific location such as the periplasmic space of bacteria.
Expression/Production System
Different organisms may be used to express a gene's target protein, and the
expression vector used will therefore have elements specific for use in the
particular organism. The most commonly used organism for protein
production is the bacterium Escherichia coli. However, not all proteins can
be successfully expressed in E. coli, or be expressed with the correct form
of post-translational modifications such as glycosylations, and other
systems may therefore be used.
Bacteria
 The expression host of choice for the expression of many proteins is
Escherichia coli as the production of heterologous protein in E. coli is
relatively simple and convenient, as well as being rapid and cheap. A large
number of E. coli expression plasmids are also available for a wide variety
of needs. Other bacteria used for protein production include Bacillus
subtilis.
 Most heterologous proteins are expressed in the cytoplasm of E. coli.
However, not all proteins formed may be soluble in the cytoplasm, and
incorrectly folded proteins formed in cytoplasm can form insoluble
aggregates called inclusion bodies. Such insoluble proteins will require
refolding, which can be an involved process and may not necessarily
produce high yield
FIG- EXPRESSION VECTOR
 Proteins which have disulphide bonds are often not able to fold correctly due to the reducing
environment in the cytoplasm which prevents such bond formation, and a possible solution is
to target the protein to the periplasmic space by the use of an N-terminal signal sequence.
 Another possibility is to manipulate the redox environment of the cytoplasm. Other more
sophisticated systems are also being developed; such systems may allow for the expression of
proteins previously thought impossible in E. coli, such as glycosylated proteins.
 The promoters used for these vector are usually based on the promoter of the lac operon or
the T7 promoter, and they are normally regulated by the lac operator. These promoters may
also be hybrids of different promoters, for example, the Tac-Promoter is a hybrid of trp and lac
promoters. Note that most commonly used lac or lac-derived promoters are based on the
lacUV5 mutant which is insensitive to catabolite repression. This mutant allows for expression of
protein under the control of the lac promoter when the growth medium contains glucose since
glucose would inhibit gene expression if wild-type lac promoter is used. Presence of glucose
nevertheless may still be used to reduce background expression through residual inhibition in
some systems.
 Examples of E. coli expression vectors are the pGEX series of vectors where glutathione S-
transferase is used as a fusion partner and gene expression is under the control of the tac
promoter, and the pET series of vectors which uses a T7 promoter.
Bacteria Contd…
 It is possible to simultaneously express two or more different
proteins in E. coli using different plasmids. However, when 2 or
more plasmids are used, each plasmid needs to use a different
antibiotic selection as well as a different origin of replication,
otherwise one of the plasmids may not be stably maintained.
Many commonly used plasmids are based on the ColE1 replicon
and are therefore incompatible with each other; in order for a
ColE1-based plasmid to coexist with another in the same cell,
the other would need to be of a different replicon, e.g. a p15A
replicon-based plasmid such as the pACYC series of plasmids.
Another approach would be to use a single two-cistron vector
or design the coding sequences in tandem as a bi- or poly-
cistronic construct.
Yeast
 A yeast commonly used for protein production is Pichia pastoris. Examples of yeast expression
vector in Pichia are the pPIC series of vectors, and these vectors use the AOX1 promoter
which is inducible with methanol. The plasmids may contain elements for insertion of foreign
DNA into the yeast genome and signal sequence for the secretion of expressed protein.
Proteins with disulphide bonds and glycosylation can be efficiently produced in yeast. Another
yeast used for protein production is Kluyveromyces lactis and the gene is expressed, driven by
a variant of the strong lactase LAC4 promoter.
 Saccharomyces cerevisiae is particularly widely used for gene expression studies in yeast, for
example in yeast two-hybrid system for the study of protein-protein interaction. The vectors
used in yeast two-hybrid system contain fusion partners for two cloned genes that allow the
transcription of a reporter gene when there is interaction between the two proteins expressed
from the cloned genes.
 Baculovirus is normally used for production of glycoproteins, although the glycosylations may
be different from those found in vertebrates. In general, it is safer to use than mammalian
virus as it has a limited host range and does not infect vertebrates without modifications.
YAC Cloning System
 A YAC is designed to clone a large segments of DNA (100kb), which is then
maintained as a separate chromosome in the host yeast cell.
 It is highly stable and has been used for the physical mapping of human
genomic libraries.
 It has a sequences that act as ARS for replication, centromere for cell
division, and telomere for stability.
 To date, they have not been used as expression systems for the
commercial production.
Intercellular Production in Yeast
 Human Cu/ZnSOD c DNA was cloned between the promoter and
termination-polyadenylation sequence of the yeast GAPD gene and
subsequently used to transform LEU mutant host cell.
Secretion of Heterologous Proteins
 Proteins may also be production for secretion.
 In this system, any glycosylated protein is selected
 The coding sequence of recombinant protein must be cloned downstream of a
leader sequence, the appropriate posttranslational modifications occur, and an
active recombinant Protein in secreted.
 The leader peptide is removed by endoprotease that recognizes the Lys-Arg.
 For Example-a properly processed and activity from the protein hirudine;
coding sequence to allow expression that is cleaved away in processing.
 Producing a recombinant in yeast rather than in bacteria is to ensure the
proper folding.
Difference Between Cloning Vector &
Expression Vector
Secretion of heterologous proteins
Cell- Free System
 E. coli cell lysate containing the cellular components required for
transcription and translation are used in this in vitro method of protein
production. The advantage of such system is that protein may be
produced much faster than those produced in vivo since it does not
require time to culture the cells, but it is also more expensive. Vectors used
for E. coli expression can be used in this system although specifically
designed vectors for this system are also available. Eukaryotic cell extracts
may also be used in other cell-free systems, for example, the wheat germ
cell-free expression systems. Mammalian cell-free systems have also been
produced.
Vector Design
 Generalized mammalian expression vector.
 The MCS and SMG are under the control of eukaryotic promoter, polyadenylation, and
terminal sequences.
 An intron enhance the production of heterologous protein.
 The AMPr gene is used for selecting transformed E.COLI.
 For the best results, a gene of interest must be equipped with translation control
sequence
 A gene of interest with a various sequences that enhance translation and facilitate both
secretion and purification.
 A Kozak sequence, specific sequence surrounding the AUG start codon, signal
sequence, protein affinity tag for purification, protelaolytic cleavage site,and stop codon.
 The 5’ & 3’ UTR increase the efficiency of translation and contribute to mRNA stability.
Two Vector Expression System
Two Vector Expression System contd….
Application
 LABORATORY
 Expression vector in an expression host is now the usual method used in
laboratories to produce proteins for research. Most proteins are produced
in E. coli, but for glycosylated proteins and those with disulphide bonds,
yeast, Baculovirus and mammalian systems may be used.
Production of Peptide and Protein
Pharmaceuticals
 Most protein pharmaceuticals are now produced through recombinant DNA
technology using expression vectors. These peptide and protein
pharmaceuticals may be hormones, vaccines, antibiotics, antibodies, and
enzymes. The first human recombinant protein used for disease management,
insulin, was introduced in 1982. Biotechnology allows these peptide and
protein pharmaceuticals, some of which were previously rare or difficult to
obtain, to be produced in large quantity. It also reduces the risks of
contaminants such as host viruses, toxins and prions. Examples from the past
include prion contamination in growth hormone extracted from pituitary
glands harvested from human cadavers, which caused Creutzfeldt–Jakob
disease in patients receiving treatment for dwarfism, and viral contaminants in
clotting factor VIII isolated from human blood that resulted in the transmission
of viral diseases such as hepatitis and AIDS. Such risk is reduced or removed
completely when the proteins are produced in non-human host cells.
Reference
https://www.cusabio.com/c-20273.html
https://en.wikipedia.org/wiki/Expression_vector

More Related Content

What's hot

Host cell and vectors
Host cell and vectorsHost cell and vectors
Host cell and vectorsDr. R Salini
 
Messenger RNA (mRNA) enrichment
Messenger RNA (mRNA) enrichmentMessenger RNA (mRNA) enrichment
Messenger RNA (mRNA) enrichmentJasmin Russel
 
shotgun sequncing
 shotgun sequncing shotgun sequncing
shotgun sequncingSAIFALI444
 
Lectut btn-202-ppt-l5. yeast cloning vectors (1)
Lectut btn-202-ppt-l5. yeast cloning vectors (1)Lectut btn-202-ppt-l5. yeast cloning vectors (1)
Lectut btn-202-ppt-l5. yeast cloning vectors (1)Rishabh Jain
 
Site directed mutagenesis
Site  directed mutagenesisSite  directed mutagenesis
Site directed mutagenesisZain Khadim
 
Phagemid and bac vectors
Phagemid and bac vectorsPhagemid and bac vectors
Phagemid and bac vectorsPromila Sheoran
 
Bacterial genomic organization
Bacterial genomic organizationBacterial genomic organization
Bacterial genomic organizationNegash Alamin
 
Genomic library construction
Genomic library constructionGenomic library construction
Genomic library constructionGurvinder Kaur
 
pET vector. Plasmid for Expression by T7 RNA Polymerase.
pET vector. Plasmid for Expression by T7 RNA Polymerase.pET vector. Plasmid for Expression by T7 RNA Polymerase.
pET vector. Plasmid for Expression by T7 RNA Polymerase.MuhammadMujahid58
 
Steps and strategies of gene cloning
Steps and strategies of gene cloningSteps and strategies of gene cloning
Steps and strategies of gene cloningMalar Malar
 
Artificial chromosome
Artificial chromosomeArtificial chromosome
Artificial chromosomeSafali Gupta
 

What's hot (20)

Host cell and vectors
Host cell and vectorsHost cell and vectors
Host cell and vectors
 
Exprssion vector
Exprssion vectorExprssion vector
Exprssion vector
 
Expression system final
Expression system finalExpression system final
Expression system final
 
Messenger RNA (mRNA) enrichment
Messenger RNA (mRNA) enrichmentMessenger RNA (mRNA) enrichment
Messenger RNA (mRNA) enrichment
 
shotgun sequncing
 shotgun sequncing shotgun sequncing
shotgun sequncing
 
Genomic library
Genomic libraryGenomic library
Genomic library
 
Lectut btn-202-ppt-l5. yeast cloning vectors (1)
Lectut btn-202-ppt-l5. yeast cloning vectors (1)Lectut btn-202-ppt-l5. yeast cloning vectors (1)
Lectut btn-202-ppt-l5. yeast cloning vectors (1)
 
cloning and expression system in yeast
cloning and expression system in yeastcloning and expression system in yeast
cloning and expression system in yeast
 
Site directed mutagenesis
Site  directed mutagenesisSite  directed mutagenesis
Site directed mutagenesis
 
Phagemid and bac vectors
Phagemid and bac vectorsPhagemid and bac vectors
Phagemid and bac vectors
 
Phage display
Phage displayPhage display
Phage display
 
Bacterial genomic organization
Bacterial genomic organizationBacterial genomic organization
Bacterial genomic organization
 
Genomic library construction
Genomic library constructionGenomic library construction
Genomic library construction
 
Cloning strategies
Cloning strategiesCloning strategies
Cloning strategies
 
pET vectors
pET vectorspET vectors
pET vectors
 
pET vector. Plasmid for Expression by T7 RNA Polymerase.
pET vector. Plasmid for Expression by T7 RNA Polymerase.pET vector. Plasmid for Expression by T7 RNA Polymerase.
pET vector. Plasmid for Expression by T7 RNA Polymerase.
 
Steps and strategies of gene cloning
Steps and strategies of gene cloningSteps and strategies of gene cloning
Steps and strategies of gene cloning
 
P bluescript
P bluescriptP bluescript
P bluescript
 
Artificial chromosome
Artificial chromosomeArtificial chromosome
Artificial chromosome
 
DNA footprinting
DNA footprintingDNA footprinting
DNA footprinting
 

Similar to Gene expression vector by tahura mariyam ansari

Promoters used in expression vectors
Promoters used in expression vectorsPromoters used in expression vectors
Promoters used in expression vectorsNaSir32
 
Expression vector
Expression vectorExpression vector
Expression vectorAhmed Madni
 
Expression vectors
Expression vectorsExpression vectors
Expression vectorsUrmila N Pai
 
Vector engineering and codon optimization
Vector engineering and codon optimizationVector engineering and codon optimization
Vector engineering and codon optimizationPiyush Jamwal
 
Transcriptional and Post-transcriptional Regulation of Gene Expression.pptx
Transcriptional and Post-transcriptional Regulation of Gene Expression.pptxTranscriptional and Post-transcriptional Regulation of Gene Expression.pptx
Transcriptional and Post-transcriptional Regulation of Gene Expression.pptxPrabhatSingh628463
 
shuttle vectors ppts.pptx
shuttle vectors ppts.pptxshuttle vectors ppts.pptx
shuttle vectors ppts.pptxAllahNawaz38
 
Regulation of gene expression in eukaryotes
Regulation of gene expression in eukaryotesRegulation of gene expression in eukaryotes
Regulation of gene expression in eukaryotesAnna Purna
 
Expression vector, baculovirus expression vector
Expression vector, baculovirus expression vectorExpression vector, baculovirus expression vector
Expression vector, baculovirus expression vectorPromila Sheoran
 
08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid Vector08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid VectorJeneesh Jose
 
Plasmid as a Cloning Vector
Plasmid as a Cloning VectorPlasmid as a Cloning Vector
Plasmid as a Cloning VectorAnik Banik
 
Cloning vectors & gene constructs
Cloning vectors & gene constructsCloning vectors & gene constructs
Cloning vectors & gene constructsKavya Kondaka
 
Eukayotic expression - vimmi.
Eukayotic expression - vimmi.Eukayotic expression - vimmi.
Eukayotic expression - vimmi.Vimlesh Gupta
 
Regulation of gene expression
Regulation of gene expressionRegulation of gene expression
Regulation of gene expressionRamesh Gupta
 
Basic architecture of expression vectors
Basic architecture of expression vectorsBasic architecture of expression vectors
Basic architecture of expression vectorsRashmi Rawat
 
BCH 805_gene regulation_Lectures.pptx
BCH 805_gene regulation_Lectures.pptxBCH 805_gene regulation_Lectures.pptx
BCH 805_gene regulation_Lectures.pptxToluwalopeFash
 

Similar to Gene expression vector by tahura mariyam ansari (20)

Promoters used in expression vectors
Promoters used in expression vectorsPromoters used in expression vectors
Promoters used in expression vectors
 
Expression vector
Expression vectorExpression vector
Expression vector
 
Expression vectors
Expression vectorsExpression vectors
Expression vectors
 
Vector engineering and codon optimization
Vector engineering and codon optimizationVector engineering and codon optimization
Vector engineering and codon optimization
 
299860 633981096231012500
299860 633981096231012500299860 633981096231012500
299860 633981096231012500
 
Transcriptional and Post-transcriptional Regulation of Gene Expression.pptx
Transcriptional and Post-transcriptional Regulation of Gene Expression.pptxTranscriptional and Post-transcriptional Regulation of Gene Expression.pptx
Transcriptional and Post-transcriptional Regulation of Gene Expression.pptx
 
Expression vectors
Expression vectorsExpression vectors
Expression vectors
 
shuttle vectors ppts.pptx
shuttle vectors ppts.pptxshuttle vectors ppts.pptx
shuttle vectors ppts.pptx
 
Regulation of gene expression in eukaryotes
Regulation of gene expression in eukaryotesRegulation of gene expression in eukaryotes
Regulation of gene expression in eukaryotes
 
Expression vector, baculovirus expression vector
Expression vector, baculovirus expression vectorExpression vector, baculovirus expression vector
Expression vector, baculovirus expression vector
 
Vector Engineering.pptx
Vector Engineering.pptxVector Engineering.pptx
Vector Engineering.pptx
 
08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid Vector08 Kjm206 Expression Vector, Plasmid Vector
08 Kjm206 Expression Vector, Plasmid Vector
 
Plasmid as a Cloning Vector
Plasmid as a Cloning VectorPlasmid as a Cloning Vector
Plasmid as a Cloning Vector
 
Cloning vectors & gene constructs
Cloning vectors & gene constructsCloning vectors & gene constructs
Cloning vectors & gene constructs
 
E.coli promoters
E.coli promotersE.coli promoters
E.coli promoters
 
Expression vectors
Expression vectorsExpression vectors
Expression vectors
 
Eukayotic expression - vimmi.
Eukayotic expression - vimmi.Eukayotic expression - vimmi.
Eukayotic expression - vimmi.
 
Regulation of gene expression
Regulation of gene expressionRegulation of gene expression
Regulation of gene expression
 
Basic architecture of expression vectors
Basic architecture of expression vectorsBasic architecture of expression vectors
Basic architecture of expression vectors
 
BCH 805_gene regulation_Lectures.pptx
BCH 805_gene regulation_Lectures.pptxBCH 805_gene regulation_Lectures.pptx
BCH 805_gene regulation_Lectures.pptx
 

More from Tahura Mariyam Ansari

microbial ecology and microbial interaction
microbial ecology and microbial interactionmicrobial ecology and microbial interaction
microbial ecology and microbial interactionTahura Mariyam Ansari
 
Presentation on genetics of nitrogen fixation by Tahura Mariyam
Presentation on genetics of nitrogen fixation by Tahura MariyamPresentation on genetics of nitrogen fixation by Tahura Mariyam
Presentation on genetics of nitrogen fixation by Tahura MariyamTahura Mariyam Ansari
 
literature review on research work on c. difficile
literature review on research work on c. difficileliterature review on research work on c. difficile
literature review on research work on c. difficileTahura Mariyam Ansari
 
Existence and survival of microbes in changing environmental condition
Existence and survival of microbes in changing environmental conditionExistence and survival of microbes in changing environmental condition
Existence and survival of microbes in changing environmental conditionTahura Mariyam Ansari
 
genetically modified organisms (related to IPR) by Tahura Mariyam
genetically modified organisms (related to IPR) by Tahura Mariyamgenetically modified organisms (related to IPR) by Tahura Mariyam
genetically modified organisms (related to IPR) by Tahura MariyamTahura Mariyam Ansari
 
reporter gene assays by Tahura Mariyam
reporter gene assays by Tahura Mariyam reporter gene assays by Tahura Mariyam
reporter gene assays by Tahura Mariyam Tahura Mariyam Ansari
 
Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...
Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...
Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...Tahura Mariyam Ansari
 
Molecular markers by tahura mariyam ansari
Molecular markers by tahura mariyam ansariMolecular markers by tahura mariyam ansari
Molecular markers by tahura mariyam ansariTahura Mariyam Ansari
 

More from Tahura Mariyam Ansari (9)

microbial ecology and microbial interaction
microbial ecology and microbial interactionmicrobial ecology and microbial interaction
microbial ecology and microbial interaction
 
Presentation on genetics of nitrogen fixation by Tahura Mariyam
Presentation on genetics of nitrogen fixation by Tahura MariyamPresentation on genetics of nitrogen fixation by Tahura Mariyam
Presentation on genetics of nitrogen fixation by Tahura Mariyam
 
literature review on research work on c. difficile
literature review on research work on c. difficileliterature review on research work on c. difficile
literature review on research work on c. difficile
 
Existence and survival of microbes in changing environmental condition
Existence and survival of microbes in changing environmental conditionExistence and survival of microbes in changing environmental condition
Existence and survival of microbes in changing environmental condition
 
genetically modified organisms (related to IPR) by Tahura Mariyam
genetically modified organisms (related to IPR) by Tahura Mariyamgenetically modified organisms (related to IPR) by Tahura Mariyam
genetically modified organisms (related to IPR) by Tahura Mariyam
 
reporter gene assays by Tahura Mariyam
reporter gene assays by Tahura Mariyam reporter gene assays by Tahura Mariyam
reporter gene assays by Tahura Mariyam
 
Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...
Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...
Genetic transformation method in mammals cell by NIDHI MISHRA and tahura mari...
 
Molecular markers by tahura mariyam ansari
Molecular markers by tahura mariyam ansariMolecular markers by tahura mariyam ansari
Molecular markers by tahura mariyam ansari
 
Fermented milk products
Fermented milk productsFermented milk products
Fermented milk products
 

Recently uploaded

EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherRemote DBA Services
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...apidays
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesrafiqahmad00786416
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontologyjohnbeverley2021
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobeapidays
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century educationjfdjdjcjdnsjd
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyKhushali Kathiriya
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Angeliki Cooney
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businesspanagenda
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Bhuvaneswari Subramani
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Victor Rentea
 

Recently uploaded (20)

EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontology
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 

Gene expression vector by tahura mariyam ansari

  • 1. TOPIC- GENE EXPRESSION VECTOR PRESENTED BY: TAHURA MARIYAM MSc. MICROBIOLOGY PRENENTED TO: Dr. Gurudayal Ram (Assistant prof. Sr. Grade) DEPARTMENT OF INDUSTRIAL MICROBIOLOGY JACOB INSTITUTE OF BIOTECHNOLOGY AND BIO-ENGINEERING SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE,TECHNOLOGY, AND SCIENCES, PRAYAGRAJ
  • 2. Content 1. INTRODUCTION 2. ELEMENTS OF EXPRESSION VECTOR 3. ELEMENTS OF EXPRESSION 4. PROTEIN TAGS 5. OTHERS 6. EXPRESSION/PRODUCTION VECTOR  BACTERIA  YEAST  CELL-FREE SYSTEM 7. APPLICATION  PRODUCTION OF PEPTIDE AND PROTEIN PHARMACEUTICALS
  • 3. Introduction  An expression vector, otherwise known as an expression construct, is usually a plasmid or virus designed for gene expression in cells. The vector is used to introduce a specific gene into a target cell, and can commandeer the cell's mechanism for protein synthesis to produce the protein encoded by the gene. Expression vectors are the basic tools in biotechnology for the production of proteins.  The vector is engineered to contain regulatory sequences that act as enhancer and promoter regions and lead to efficient transcription of the gene carried on the expression vector. The goal of a well-designed expression vector is the efficient production of protein, and this may be achieved by the production of significant amount of stable messenger RNA, which can then be translated into protein. The expression of a protein may be tightly controlled, and the protein is only produced in significant quantity when necessary through the use of an inducer, in some systems however the protein may be expressed constitutively. Escherichia coli is commonly used as the host for protein production, but other cell types may also be used. An example of the use of expression vector is the production of insulin, which is used for medical treatments of diabetes.
  • 4. Expression Vector  The cloning vector containing suitable expression signals to have maximum gene for expression is called expression vector.  The following expression signals are introduced into gene cloned vectors are get maximum expression  Insertion of strong promoter.  Insertion of strong termination codon.  Adjustment of distance between promoter and cloned gene.  Insertion of transcription termination sequence.
  • 5. Choice of expression vector  Strong promoter  Intact ORF  Ribosomal binding site  Termination sequence
  • 6. Expression in Prokaryotes  Promoter-commonly used inducible promoter are promoters derived from lac operon and the T7 promoter. Other strong promoters used include Trp  promoter and Tac promoter, which a hybrid of both the Trp and Lac operon promoters  Ribosome binding site(RBS) following the promoter, and promoter efficient translation of the protein of interest.  Translation initiation site-shine dalgarno sequence enclosed in the RBS,8 base-pair upstream of the AUG start codon.
  • 7. Post-Translational Modification  Eukaryotic protein synthesis occurs in cytoplasm or on the endoplasmic reticulum.  These protein are further are further post translation processed that is required for protein activity and stability.  Disulfide isomerase also make sure that the proteins produced have the correct configuration  The proper glycosylation that are necessary for protien conformation, localization by interacting with specific receptor and increase stability.
  • 8. Eukaryotic Expression System  Eukaryote expression vectors require sequence that encode for.  Polyadenylation tail: creates a polyadenylation tail at the end of the transcribed pre-mRNA that protects mRNA from exonucleases and ensures transcriptional termination: stabilizers mRNA production.  Minimal UTR length: UTRs contains a specific characteristics that may impede transcriptional or translation, and thus the shortest UTRs or none at are encoded for in optimal expression vectors.  Kozak sequence: vectors should encode for a Kozak sequence in the m RNA, which assembles the ribosome for translation of the m RNA.
  • 9. Eukaryotic Expression System contd….  Eukaryote expression vector require sequence that encode for.  Polyadenylation tail: creates a polyadenylation tail at the end of the transcribed pre-m RNA that protects the m RNA fromexonucleases and ensure transcriptional and translational termination: stabilizers m RNA production.  Minimal UTR length: UTRs contains specific characteristics that may impede transcription or translation, and thus the shortest UTRs or none at all are encoded for in optimal expression vectors.  Kozak sequence: vectors should encode encode for kozak sequence in the m RNA, which assembles the ribosome for translation of the m RNA.
  • 10. Element of of expression vector  An expression vector has features that any vector may have, such as an origin of replication, a selectable marker, and a suitable site for the insertion of a gene like the multiple cloning site. The cloned gene may be transferred from a specialized cloning vector to an expression vector, although it is possible to clone directly into an expression vector. The cloning process is normally performed in Escherichia coli. Vectors used for protein production in organisms other than E.coli may have, in addition to a suitable origin of replication for its propagation in E. coli, elements that allow them to be maintained in another organism, and these vectors are called shuttle vectors.
  • 11.  The major feature of a eukaryotic expression vector are a promoter, a multiple cloning site, DNA segment for termination and polyadenylation, selectable marker, original of replication in E.coli and eukaryotic cell and Ampr for marker in E.coli
  • 12. Eukaryotic Expression System  Saccharomyces cerevisiae  Pichia pastoris  Baculovirus-insect cell lines  Mammalian systems
  • 13. Elements of Expression Vector contd….  An expression vector must have elements necessary for gene expression. These may include a promoter, the correct translation initiation sequence such as a ribosomal binding site and start codon, a termination codon, and a transcription termination sequence. There are differences in the machinery for protein synthesis between prokaryotes and eukaryotes, therefore the expression vectors must have the elements for expression that are appropriate for the chosen host. For example, prokaryotes expression vectors would have a Shine- Dalgarno sequence at its translation initiation site for the binding of ribosomes, while eukaryotes expression vectors would contain the Kozak consensus sequence.  The promoter initiates the transcription and is therefore the point of control for the expression of the cloned gene. The promoters used in expression vector are normally inducible, meaning that protein synthesis is only initiated when required by the introduction of an inducer such as IPTG. Gene expression however may also be constitutive (i.e. protein is constantly expressed) in some expression vectors. Low level of constitutive protein synthesis may occur even in expression vectors with tightly controlled promoters.
  • 14. Protein Tags After the expression of the gene product, it is usually necessary to purify the expressed protein; however, separating the protein of interest from the great majority of proteins of the host cell can be a protracted process. To make this purification process easier, a purification tag may be added to the cloned gene. This tag could be histidine (His) tag, other marker peptides, or a fusion partners such as glutathione S-transferase or maltose-binding protein. Some of these fusion partners may also help to increase the solubility of some expressed proteins. Other fusion proteins such as green fluorescent protein may act as a reporter gene for the identification of successful cloned genes, or they may be used to study protein expression in cellular imaging. OTHERS: The expression vector is transformed or transfected into the host cell for protein synthesis. Some expression vectors may have elements for transformation or the insertion of DNA into the host chromosome, for example the vir genes for plant transformation, and integrase sites for chromosomal integration. Some vectors may include targeting sequence that may target the expressed protein to a specific location such as the periplasmic space of bacteria.
  • 15. Expression/Production System Different organisms may be used to express a gene's target protein, and the expression vector used will therefore have elements specific for use in the particular organism. The most commonly used organism for protein production is the bacterium Escherichia coli. However, not all proteins can be successfully expressed in E. coli, or be expressed with the correct form of post-translational modifications such as glycosylations, and other systems may therefore be used.
  • 16. Bacteria  The expression host of choice for the expression of many proteins is Escherichia coli as the production of heterologous protein in E. coli is relatively simple and convenient, as well as being rapid and cheap. A large number of E. coli expression plasmids are also available for a wide variety of needs. Other bacteria used for protein production include Bacillus subtilis.  Most heterologous proteins are expressed in the cytoplasm of E. coli. However, not all proteins formed may be soluble in the cytoplasm, and incorrectly folded proteins formed in cytoplasm can form insoluble aggregates called inclusion bodies. Such insoluble proteins will require refolding, which can be an involved process and may not necessarily produce high yield
  • 18.  Proteins which have disulphide bonds are often not able to fold correctly due to the reducing environment in the cytoplasm which prevents such bond formation, and a possible solution is to target the protein to the periplasmic space by the use of an N-terminal signal sequence.  Another possibility is to manipulate the redox environment of the cytoplasm. Other more sophisticated systems are also being developed; such systems may allow for the expression of proteins previously thought impossible in E. coli, such as glycosylated proteins.  The promoters used for these vector are usually based on the promoter of the lac operon or the T7 promoter, and they are normally regulated by the lac operator. These promoters may also be hybrids of different promoters, for example, the Tac-Promoter is a hybrid of trp and lac promoters. Note that most commonly used lac or lac-derived promoters are based on the lacUV5 mutant which is insensitive to catabolite repression. This mutant allows for expression of protein under the control of the lac promoter when the growth medium contains glucose since glucose would inhibit gene expression if wild-type lac promoter is used. Presence of glucose nevertheless may still be used to reduce background expression through residual inhibition in some systems.  Examples of E. coli expression vectors are the pGEX series of vectors where glutathione S- transferase is used as a fusion partner and gene expression is under the control of the tac promoter, and the pET series of vectors which uses a T7 promoter.
  • 19. Bacteria Contd…  It is possible to simultaneously express two or more different proteins in E. coli using different plasmids. However, when 2 or more plasmids are used, each plasmid needs to use a different antibiotic selection as well as a different origin of replication, otherwise one of the plasmids may not be stably maintained. Many commonly used plasmids are based on the ColE1 replicon and are therefore incompatible with each other; in order for a ColE1-based plasmid to coexist with another in the same cell, the other would need to be of a different replicon, e.g. a p15A replicon-based plasmid such as the pACYC series of plasmids. Another approach would be to use a single two-cistron vector or design the coding sequences in tandem as a bi- or poly- cistronic construct.
  • 20. Yeast  A yeast commonly used for protein production is Pichia pastoris. Examples of yeast expression vector in Pichia are the pPIC series of vectors, and these vectors use the AOX1 promoter which is inducible with methanol. The plasmids may contain elements for insertion of foreign DNA into the yeast genome and signal sequence for the secretion of expressed protein. Proteins with disulphide bonds and glycosylation can be efficiently produced in yeast. Another yeast used for protein production is Kluyveromyces lactis and the gene is expressed, driven by a variant of the strong lactase LAC4 promoter.  Saccharomyces cerevisiae is particularly widely used for gene expression studies in yeast, for example in yeast two-hybrid system for the study of protein-protein interaction. The vectors used in yeast two-hybrid system contain fusion partners for two cloned genes that allow the transcription of a reporter gene when there is interaction between the two proteins expressed from the cloned genes.  Baculovirus is normally used for production of glycoproteins, although the glycosylations may be different from those found in vertebrates. In general, it is safer to use than mammalian virus as it has a limited host range and does not infect vertebrates without modifications.
  • 21.
  • 22. YAC Cloning System  A YAC is designed to clone a large segments of DNA (100kb), which is then maintained as a separate chromosome in the host yeast cell.  It is highly stable and has been used for the physical mapping of human genomic libraries.  It has a sequences that act as ARS for replication, centromere for cell division, and telomere for stability.  To date, they have not been used as expression systems for the commercial production.
  • 23. Intercellular Production in Yeast  Human Cu/ZnSOD c DNA was cloned between the promoter and termination-polyadenylation sequence of the yeast GAPD gene and subsequently used to transform LEU mutant host cell.
  • 24. Secretion of Heterologous Proteins  Proteins may also be production for secretion.  In this system, any glycosylated protein is selected  The coding sequence of recombinant protein must be cloned downstream of a leader sequence, the appropriate posttranslational modifications occur, and an active recombinant Protein in secreted.  The leader peptide is removed by endoprotease that recognizes the Lys-Arg.  For Example-a properly processed and activity from the protein hirudine; coding sequence to allow expression that is cleaved away in processing.  Producing a recombinant in yeast rather than in bacteria is to ensure the proper folding.
  • 25. Difference Between Cloning Vector & Expression Vector
  • 27. Cell- Free System  E. coli cell lysate containing the cellular components required for transcription and translation are used in this in vitro method of protein production. The advantage of such system is that protein may be produced much faster than those produced in vivo since it does not require time to culture the cells, but it is also more expensive. Vectors used for E. coli expression can be used in this system although specifically designed vectors for this system are also available. Eukaryotic cell extracts may also be used in other cell-free systems, for example, the wheat germ cell-free expression systems. Mammalian cell-free systems have also been produced.
  • 28. Vector Design  Generalized mammalian expression vector.  The MCS and SMG are under the control of eukaryotic promoter, polyadenylation, and terminal sequences.  An intron enhance the production of heterologous protein.  The AMPr gene is used for selecting transformed E.COLI.  For the best results, a gene of interest must be equipped with translation control sequence  A gene of interest with a various sequences that enhance translation and facilitate both secretion and purification.  A Kozak sequence, specific sequence surrounding the AUG start codon, signal sequence, protein affinity tag for purification, protelaolytic cleavage site,and stop codon.  The 5’ & 3’ UTR increase the efficiency of translation and contribute to mRNA stability.
  • 30. Two Vector Expression System contd….
  • 31. Application  LABORATORY  Expression vector in an expression host is now the usual method used in laboratories to produce proteins for research. Most proteins are produced in E. coli, but for glycosylated proteins and those with disulphide bonds, yeast, Baculovirus and mammalian systems may be used.
  • 32. Production of Peptide and Protein Pharmaceuticals  Most protein pharmaceuticals are now produced through recombinant DNA technology using expression vectors. These peptide and protein pharmaceuticals may be hormones, vaccines, antibiotics, antibodies, and enzymes. The first human recombinant protein used for disease management, insulin, was introduced in 1982. Biotechnology allows these peptide and protein pharmaceuticals, some of which were previously rare or difficult to obtain, to be produced in large quantity. It also reduces the risks of contaminants such as host viruses, toxins and prions. Examples from the past include prion contamination in growth hormone extracted from pituitary glands harvested from human cadavers, which caused Creutzfeldt–Jakob disease in patients receiving treatment for dwarfism, and viral contaminants in clotting factor VIII isolated from human blood that resulted in the transmission of viral diseases such as hepatitis and AIDS. Such risk is reduced or removed completely when the proteins are produced in non-human host cells.